You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-precursor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting
  • B Precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 25, 2023

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia Trial in Japan (Blinatumomab)

Completed
Has Results
  • Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia
  • Nagoya-shi, Aichi, Japan
  • +15 more
Dec 8, 2022

B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • single dose of CNCT19
  • (no location specified)
Dec 19, 2022

B-Precursor ALL Trial in Germany (Blinatumomab)

Recruiting
  • B-Precursor ALL
  • Frankfurt (Main), Hessen, Germany
  • +20 more
Aug 16, 2022

Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

Completed
Has Results
  • Relapsed/Refractory Philadelphia Positive B-precursor ALL
  • Duarte, California
  • +21 more
Sep 8, 2022

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Trial in Worldwide

Active, not recruiting
  • Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
  • Brexucabtagene Autoleucel (KTE-X19)
  • +2 more
  • Los Angeles, California
  • +30 more
Nov 2, 2022

ALL, Recurrent, Adult Trial in Germany (Blinatumomab)

Active, not recruiting
  • ALL, Recurrent, Adult
  • Frankfurt (Main), Hessen, Germany
  • +21 more
Mar 16, 2022

B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • (no location specified)
Oct 10, 2023

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 20, 2023

Acute Lymphoblastic Leukemia Trial in Tianjin (CN201)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Oct 14, 2022

B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

Recruiting
  • B-Cell Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The first affiliated hospital of Soochow University
Sep 26, 2022

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
Has Results
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Sep 13, 2022

Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

Completed
  • Acute Lymphoblastic Leukemia
    • Brno, Czechia
    • +9 more
    Sep 12, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 16, 2023

    Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Trial in Worldwide (brexucabtagene autoleucel, Cyclophosphamide,

    Active, not recruiting
    Has Results
    • Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
    • brexucabtagene autoleucel
    • +2 more
    • La Jolla, California
    • +32 more
    Mar 16, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 22, 2023

    Pediatric ALL, B Cell, Minimal Residual Disease Trial in Seoul (Blinatumomab for Injection)

    Recruiting
    • Pediatric ALL, B Cell
    • Minimal Residual Disease
    • Blinatumomab for Injection
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Feb 20, 2022

    Lymphoma, B-Cell, Chronic Lymphocytic Leukemia, Precursor B-Cell Acute Lymphoblastic Leukemia Trial in United States (FT819,

    Recruiting
    • Lymphoma, B-Cell
    • +2 more
    • Birmingham, Alabama
    • +7 more
    Jul 28, 2022

    B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • QH103 Cell Injection
    • +2 more
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Sep 21, 2023

    MRD Detection by NGS in Pediatric B-ALL

    Completed
    • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
    • MRD
    • Hangzhou, Zhejiang, China
      The Children's Hospital of Zhejiang University School of Medicin
    Jul 25, 2023

    Refractory B-cell Acute Lymphoblastic Leukemia Trial in Houston (Mosunetuzumab)

    Not yet recruiting
    • Refractory B-cell Acute Lymphoblastic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2023